Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
Written By
Thurman AR, Brache V, Cochon L, Ouattara LA, Chandra N, Jacot T, et al.
